Last reviewed · How we verify
NCT02235974: CPASS
Critical Periods After Stroke Study (CPASS)
NA trial testing Early Intensive upper extremity motor training in Stroke in 150 participants. Status unknown.
31 December 2020
Quick facts
| Lead sponsor | MedStar National Rehabilitation Network |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 150 |
| Start date | 26 August 2014 |
| Primary completion | 31 December 2020 |
| Estimated completion | 31 January 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Early Intensive upper extremity motor training
- Sub-acute intensive upper extremity motor training
- Chronic intensive upper extremity motor training
- Control
Conditions studied
- Stroke — all drugs for Stroke →
- Brain Infarction — all drugs for Brain Infarction →
- Brain Ischemia — all drugs for Brain Ischemia →
- Cerebral Infarction — all drugs for Cerebral Infarction →
Sponsor
MedStar National Rehabilitation Network
Who can join
21 and older, any sex, with Stroke or Brain Infarction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To perform an exploratory single center randomized study that will form the basis for a larger scale, more definitive randomized clinical trial to determine the optimal time after stroke for intensive motor training. The investigators will perform a prospective exploratory study of upper extremity (UE) motor training delivered at higher than usual intensity at three different time points after stroke: * early (initiated within 30 days) * subacute/outpatient (initiated within 2-3 months) * chronic (initiated within 6-9 months) The control group will not receive the therapy intervention during the 1-year study. Outcome measures will be assessed at baseline, pre-treatment, post-treatment, 6 months and one year after stroke onset. Compared to individuals randomized during the outpatient (2-3 months after stroke onset) or chronic (6-9 months after stroke onset) time points, participants randomized to early intensive motor training will show greater upper extremity motor improvement measured at one year post stroke.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Repetitive task training for improving functional ability after stroke.
French B, Thomas LH, Coupe J, McMahon NE, et al · · 2016 · cited 231× · PMID 27841442 · DOI 10.1002/14651858.cd006073.pub3 -
Why Are Stroke Rehabilitation Trial Recruitment Rates in Single Digits?
Geed S, Feit P, Edwards DF, Dromerick AW. · · 2021 · cited 15× · PMID 34168611 · DOI 10.3389/fneur.2021.674237 -
The Critical Period After Stroke Study (CPASS) Upper Extremity Treatment Protocol.
Barth J, Geed S, Mitchell A, Brady KP, et al · · 2023 · cited 4× · PMID 37744191 · DOI 10.1016/j.arrct.2023.100282
Verify or expand the search:
- PubMed search for NCT02235974
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Stroke
Currently open trials in the same condition.
- NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
- NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
- NCT07356011 — Exoskeleton for Balance · NA · recruiting
- NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
- NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting
Other MedStar National Rehabilitation Network trials
Trials by the same sponsor.
- NCT06214494 — Blood Flow Restricted High-Intensity Treadmill Training on Independently Ambulating Chronic Ischemic CVA Survivors · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02235974 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by MedStar National Rehabilitation Network
- Last refreshed: 7 April 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02235974.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing